A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer
Research output: Contribution to journal › Journal article › Research › peer-review
Previous reports have shown that the proteomic markers apolipoprotein A1, hepcidin, transferrin, inter-alpha trypsin IV internal fragment, transthyretin, connective-tissue activating protein 3 and beta-2 microglobulin may discriminate between a benign pelvic mass and ovarian cancer (OC). The aim was to determine if these serum proteomic biomarkers alone as well as in combination with age and serum CA125, could be helpful in triage of women with a pelvic mass.
|Number of pages||6|
|Publication status||Published - 2011|